Abstract
Cardiovascular disease (CVD) in women remains understudied, under-recognized, underdiagnosed and undertreated. Initiatives such as the Lancet Women and Cardiovascular Disease Commission help to identify sex and gender-related gaps in research, care and outcomes and to guide next steps in addressing them. This article highlights important aspects of the Lancet Commission report and expands on the evidence and proposed strategies for reducing the global burden of CVD in women. Furthermore, the article explores the benefits of cross-specialty collaborations for the treatment and prevention of CVD in women and discusses the impact of gender-related disparities in academic cardiology.
摘要
女性心血管疾病(CVD)仍未得到充分的研究、认识、诊断和治疗。柳叶刀妇女和心血管疾病委员会等倡议有助于确定研究、保健和成果方面的性和性别差距, 并指导这些差距下一步的解决。本文着重介绍了柳叶刀委员会报告的重要方面, 并阐述了减少全球妇女心血管疾病负担的证据和建议的战略。此外, 文章还探讨了跨学科合作对女性心血管疾病治疗和预防的益处, 并讨论了心脏病学中性别差异的影响。
Source of funding
None.